Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - BofA Securities raised its price target on BWX Technologies (NYSE:BWXT) to $220.00 from $155.00 on Wednesday, while maintaining a Buy rating on the stock. The company’s stock has already delivered impressive returns, surging 86% over the past year and 62% year-to-date.
The price target increase represents a significant upward revision, with BofA applying a 2.4x relative multiple compared to the previous 1.7x multiple in its valuation model.
BofA Securities noted that BWX Technologies’ naval nuclear power plants remain in high demand, with a recent $2.6 billion Navy pricing agreement driving record backlog for the company.
The firm believes BWX Technologies is uniquely positioned to support deployment of military and space nuclear power, providing strong growth potential in these sectors.
BofA also highlighted potential upside to BWX Technologies’ Commercial business from accelerating development of small modular reactors (SMRs), citing the company’s "enviable position as a critical merchant supplier" in this growing market.
In other recent news, BWX Technologies reported impressive financial results for the second quarter of 2025. The company achieved earnings per share of $1.02, significantly surpassing the projected $0.79, marking a 29.11% surprise. Revenue also exceeded expectations, totaling $764 million compared to the forecasted $708.55 million. Following these results, management raised its outlook for the year. Truist Securities responded by increasing its price target for BWX Technologies from $114 to $145, while maintaining a Hold rating on the stock. These developments highlight a period of strong performance and optimistic projections for the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.